Takeda names GSK vaccine chief as COO; PharmAthene backs out of Theraclone merger;

> Takeda has named the president of GlaxoSmithKline's ($GSK) vaccine unit as its COO. News (sub. req.)

> PharmAthene ($PIP) is backing out of its proposed merger with Theraclone. Article

> Regulators in the Philippines have found counterfeit rabies vaccines. Item

> CMC Biologics is to manufacture a placental malaria vaccine. Release

> Sex and money are just two of several issues holding back HPV vaccines, research shows. Piece

> Only half of U.K. healthcare workers receive a routine flu vaccination. Article

> Korean CRO SillaJen has bought failed cancer vaccine Pexa-Vec. News

> The European CHMP has backed a two-dose regimen of GlaxoSmithKline's HPV vaccine. Item

> Immunicum has reported positive early-phase data for its therapeutic cancer vaccine. Release

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

Find out how PDA can help you succeed with custom solutions and training for your employees – at your facility, our facility, or virtually.

Iowa State University is working on a room-temp-stable nasal spray vaccine for COVID-19, and it recently tapped device maker Zeteo for support.

Pfizer's shot will go before an FDA expert panel on Dec. 10, with Moderna's review pegged for the 17th, Warp Speed chief Moncef Slaoui, Ph.D., said.